ABOUT THE EVENT
Date: Friday, September 11, 2026 8:30am–4pm PDT
Event Location: San Diego, CA
Metabolic disease represents one of the most active and exciting frontiers in drug development. This year, GemPharmatech’s annual symposium brings together leading researchers and industry scientists to explore the mechanisms driving obesity, insulin resistance, and cardiometabolic dysfunction, with a focus on the pathways most relevant to next-generation therapeutic intervention.
Speakers:
- Dr. Philipp E Scherer, Professor and Director, Touchstone Diabetes Center at UTSW Medical Center
- Dr. Joe Brozinick, Associate VP, Cardiometabolic Research, Eli Lilly and Company
- Dr. Kimberley D Bruce, Associate Professor of Medicine, University of Colorado Anschutz
- Dr. John A. Hangasky III, Director, Discovery Research, Prolyn
- Dr. Mark A. Rossi, Assistant Professor, Neuroscience and Cell Biology, Center for NeuroMetabolism Rutgers University
- Dr. Qinghchun Tong, Professor, UTHealth Houston
- Jian Luo, MD, Senior Director, Translational CVRM at Genentech, Inc.
Join us for an exciting day of scientific discussion, lunch, and networking.
***This event is not accepting registration from business developers.